FDA Approves Risperidone Extended-Release Injectable Option for Bipolar 1 Disorder The first under-the-skin, long-acting risperidone injection offers a new maintenance option for adults with bipolar 1 disorder. For anyone managing bipolar 1 disorder, staying consistent with daily medication can be a challenge. Busy schedules, shifting moods, and side effects can make it easy to miss doses — and even brief gaps may disrupt mood stability.... The post FDA Approves Risperidone Extended-Release Injectable Option for Bipolar 1 Disorder appeared first on bpHope.com.

FDA Approves Risperidone Extended-Release Injectable Option for Bipolar 1 Disorder #BipolarDrugs #BipolarTreatment #antipsychotics